يحاول ذهب - حر
Union Budget 2025 targets healthcare, medical education & Al, omitting medical devices.
March 2025
|Bio Spectrum
The overall macro-economic and policy direction measures announced in the Union Budget 2025, particularly focusing on cancer care, medical education, AI, R&D and innovation, is appreciable. There are many key points in the budget announcements that will strengthen the economy and propel the GDP growth. However, without any mention of investment promotion measures for the 70 per cent imports-dependent medical devices sector in the budget speech, industry disappointment was an expected reaction. Let's delve further.

Union Minister of Finance and Corporate Affairs Nirmala Sitharaman presented the Union Budget 2025-26 in Parliament on February 1, 2025. While multiple new initiatives within the healthcare sector were announced such as the establishment of new Day Care Cancer Centres in district hospitals; Full exemption from Basic Customs Duty of 36 lifesaving drugs and medicines for treating cancer, rare diseases and chronic diseases; addition of 10,000 seats in medical colleges and hospitals next year; Announcement of National Manufacturing Mission; Promotion of medical tourism etc., expectations of the Medical Devices sector have not been met.
The Indian Medical Devices Industry was expecting an increase in Custom Duty to a nominal 10 per cent to 15 per cent (and as a Predictable Tariff Policy); Correction of Inverted Duty by levying Health Cess of 5 per cent custom duty on balance Medical Devices; Trade Margin Capping by monitoring MRP of Imports; Income Tax benefits for CAPEX and R&D investments in Medical Devices. The industry was also hoping that the government could consider standardising the GST rate of 12 per cent across all medical devices as it would simplify the tax structure, ensuring consistency and ease of doing business.

هذه القصة من طبعة March 2025 من Bio Spectrum.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Bio Spectrum

Bio Spectrum
IASST synthesises new compound to combat aggressive breast cancer
A newly designed nitro-substituted organoselenium compound by Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute under the Department of Science and Technology (DST), can reduce the invasiveness of aggressive triplenegative breast cancer cells by modulating various Se Se signalling pathways.
1 min
October 2025
Bio Spectrum
DPIIT signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has signed a Memorandum of Understanding (MoU) with Pfizer Limited.
1 min
October 2025

Bio Spectrum
WHO unveils updated guideline on HIV service delivery
WHO has released an updated guideline to support integrated HIV service delivery, promote long-term adherence to antiretroviral therapy (ART), and improve the overall health and well-being of people living with HIV.
1 min
October 2025
Bio Spectrum
Scientists in Kolkata explore therapeutic potential of accessory proteins
A hidden protein that protects our cells from mechanical stress could provide a new direction to therapeutic strategies for diseases where protein stability under force is compromised like heart muscle disease or genetic disorders called laminopathies.
1 min
October 2025

Bio Spectrum
US FDA advances rare disease drug development
The US Food and Drug Administration (FDA) has introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations with significant unmet medical need and that are driven by a known genetic defect.
1 min
October 2025
Bio Spectrum
WHO updates list of essential medicines to include key cancer, diabetes treatments
The World Health Organization (WHO) has released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLC), adding new treatments for various types of cancer and for diabetes with associated comorbidities such as obesity.
1 min
October 2025
Bio Spectrum
Agilent's MMR IHC Panel pharmDx (Dako Omnis) receives European IVDR Certification
Agilent Technologies Inc. has announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer.
1 min
October 2025
Bio Spectrum
Aodh Lifesciences gets support from TDB to redefine pneumonia treatment
The Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to Aodh Lifesciences, a startup based in Hyderabad, for development of Indigenous Antibiotic Nebulisation Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
1 min
October 2025

Bio Spectrum
Antara Senior Care names Mukesh Ghuraiya as Chief Marketing Officer
Antara Senior Care, a fully integrated senior care ecosystem, has appointed Mukesh Ghuraiya as the Executive Vice-President and Chief Marketing Officer (CMO).
1 min
October 2025
Bio Spectrum
Poly Medicure acquires PendraCare Group for Rs 188.5 Cr
Poly Medicure, a Delhi-based medical device company, has announced signing of definitive agreements to acquire 90 per cent stake in PendraCare Group consisting of PendraCare Holdings and Welling Medical from Welling Holdings B.V. at an Enterprise value of Rs 188.5 crore (Euro 18.3 million).
1 min
October 2025
Listen
Translate
Change font size